Multiple Sclerosis

The Pharmacy Times® Multiple Sclerosis Resource Center is a comprehensive resource for clinical news and expert insights on treatments for multiple sclerosis.

Latest News

Metal Ion Chelators Hold Enormous Potential in Neurodegenerative Disorders
Metal Ion Chelators Hold Enormous Potential in Neurodegenerative Disorders

January 31st 2024

Monitoring metal ion concentrations and chelation therapy is hypothesized to alleviate symptoms and diseases caused by neuroinflammation.

Image credit: Juan Gärtner | stock.adobe.com
Ocrelizumab Found to Suppress Immune Activity That Worsens Multiple Sclerosis Symptoms

October 16th 2023

Image credit: wladimir1804 - stock.adobe.com
FDA Approves First Biosimilar of Natalizumab for the Treatment of Relapsing Multiple Sclerosis

August 25th 2023

Credit: freshidea - stock.adobe.com.
Study: Ofatumumab Slows Worsening Disability in Patients With Relapsing Multiple Sclerosis

May 23rd 2023

CBD Gummy Market Projected to Grow Significantly, But Growth Restraints Remain
CBD Gummy Market Projected to Grow Significantly, But Growth Restraints Remain

February 3rd 2023

Video Interviews
Podcasts
Latest CME Events & Activities

Advancing Alzheimer Disease Treatment: Updates and Insights for Managed Care

2.0 Credits / Neurology

View More

Preventing and Managing Controlled Substance Diversion Across Health Care Settings

2.0 Credits / Law

View More

Treatment Advancements and Management Strategies in Bipolar Disorder to Mitigate Challenges to Patient Care

1.0 Credit / Neurology, Psychiatry

View More

Risks and Liabilities in Pharmacy Practice

1.0 Credit / Law

View More

A Managed Care Focus on Assessing the Armamentarium for Multiple Sclerosis to Better Individualize Treatment

1.5 Credits / Neurology

View More

The Value of Early Intervention With Long-Acting Injectable Antipsychotics to Improve Adherence and Treatment of Schizophrenia

1.5 Credits / Neurology, Psychiatry

View More

The Promising Role of Novel and Emerging Therapies for Amyotrophic Lateral Sclerosis: Clinical and Managed Care Insights

1.0 Credit / Neurology

View More

Understanding the Role of IVIg and SCIg for the Management of CIDP: Information the Pharmacist Needs to Know to Optimize Care, featuring a Patient Perspective

1.5 Credits / Immunology, Neurology

View More

Rare and Treatment-Resistant Epilepsy Syndromes: Identifying and Addressing the Unmet Needs of Patients and Recognizing Opportunities for Pharmacist Intervention

1.5 Credits / Neurology

View More

Strategies for the Management and Treatment of ALS: The Value of Early Diagnosis and Clinical Intervention

3.0 Credits / Neurology

View More

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

Leveraging Managed Care to Optimize Best Practices in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

1.0 Credit / Neurology

View More

Improving Outcomes and Quality of Care in Spinal Muscular Atrophy: Updates in Treatment Advances

2.0 Credits / Neurology

View More

New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist

1.0 Credit / Neurology

View More

Navigating the Use of Targeted Therapies and Individualizing Care for Patients With Ulcerative Colitis

1.5 Credits / Gastroenterology

View More

Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden

1.5 Credits / Neurology

View More

Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care

1.5 Credits / Neurology

View More

Advances in Pharmacotherapy for Excessive Daytime Sleepiness Due to Narcolepsy

2.0 Credits / Neurology

View More

The Role of Long-Term Care and Consultant Pharmacists in the Management of Tardive Dyskinesia

1.0 Credit / Neurology

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

More News

© 2024 MJH Life Sciences

All rights reserved.